Sam Industries Ltd. (BOM:532005)

Singular Genomics Systems Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	31.37	107.19	53.99	59.58	49.84
Depreciation & Amortization	14.23	4.59	3.51	3.67	3.67
Loss (Gain) From Sale of Assets	-	3.83	-	-	-0.57
Loss (Gain) From Sale of Investments	-6.98	-102.01	5.15	-26.04	-22.08
Other Operating Activities	18.08	2.2	-3.55	4.02	-3.19
Change in Accounts Receivable	-38.5	-9.25	2.84	3.01	31.27
Change in Inventory	14.38	34.1	90.51	-31.53	-14.01
Change in Accounts Payable	24.51	-20.37	-22.45	77.19	-17.6
Operating Cash Flow	57.09	20.27	130	89.9	27.33
Operating Cash Flow Growth	181.63%	-84.41%	44.60%	229.00%	130.10%
Capital Expenditures	-400.54	-316.92	-7.46	-6.38	-13.25
Sale of Property, Plant & Equipment	-	-	-	-	0.57
Sale (Purchase) of Real Estate	-	-42.72	-125.18	-91.41	-
Investment in Securities	22.19	92.15	0.96	29.48	-15.07
Other Investing Activities	279.04	2.61	6.01	2.26	4.31
Investing Cash Flow	-99.31	-264.88	-125.67	-66.03	-23.44
Long-Term Debt Issued	62.3	264.4	-	-	-
Long-Term Debt Repaid	-	-	-15.51	-	-
Net Debt Issued (Repaid)	62.3	264.4	-15.51	-	-
Other Financing Activities	-24.46	-4.85	-2.99	-3.85	-2.26
Financing Cash Flow	37.85	259.54	-18.49	-3.85	-2.26
Miscellaneous Cash Flow Adjustments	-	-	-0	-0	-0
Net Cash Flow	-4.38	14.93	-14.17	20.01	1.63
Free Cash Flow	-343.45	-296.65	122.54	83.52	14.08
Free Cash Flow Growth	-	-	46.71%	493.42%	-
Free Cash Flow Margin	-218.79%	-145.61%	46.42%	68.29%	13.65%
Free Cash Flow Per Share	-30.99	-26.75	11.05	7.53	1.27
Cash Interest Paid	24.46	4.85	2.99	3.85	2.26
Cash Income Tax Paid	4.91	12.04	18.94	10.9	13.17
Levered Free Cash Flow	-398.56	-242.37	124.97	69.5	-43.71
Unlevered Free Cash Flow	-382.53	-238.94	126.84	71.91	-42.29
Change in Net Working Capital	31.66	7.12	-78.36	-32.62	70.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.